AHN’s new LDRT program provides a non-invasive treatment option for joint pain.
AHN radiation oncologists have honed techniques for using Low-Dose Radiation Therapy (LDRT) to treat patients with Osteoarthritis (OA) — the most common form of arthritis affecting more than 32 million Americans. Less than 10% of radiation oncologists in the U.S. are using LDRT for OA treatment.*
With the prevalence of OA expected to increase as populations age, AHN’s comprehensive LDRT program is especially critical for western Pennsylvanians, as Allegheny County is home to the second oldest population in the country.
According to Chirag Shah, MD, Chair of Radiation Oncology at AHN Cancer Institute, LDRT has existed for decades, but “what’s old is new.”
“We used to use radiation treatment for benign diseases in the U.S. for many years, and it’s a common treatment in European countries,” said Dr. Shah. “A recent resurgence of the treatment has presented us with an opportunity to build a program at AHN where patients are treated in a very standardized fashion.”
Radiation therapy uses a high-energy X-ray machine, generated by a linear accelerator, to perform targeted, localized treatment on an affected area of the body. LDRT for OA patients targets affected joints — most commonly the knees, hips, hands, feet, shoulders, and elbows.
Unlike supportive care OA treatments that are used to manage symptoms, LDRT targets the underlying inflammatory processes caused by arthritis, providing an opportunity for lasting relief. LDRT is also non-invasive compared to interventions like joint injections, which may provide short-term relief but can have higher risks for side effects.
“Our team is focused on improving a patient’s quality of life with durable pain improvement,” said Dr. Shah. “Our approach to LDRT involves closely monitoring patients and how they respond to treatment over time to ensure the best outcomes for long-term comfort and relief from arthritis pain in daily life.”
LDRT may be an effective treatment for patients that have suffered from OA (not Rheumatoid Arthritis) symptoms for several months and are unable to get a joint replacement or undergo major surgery. AHN radiation oncologists thoroughly assess a patient’s symptoms to determine whether they are a good candidate for LDRT, and what treatment method will provide the best results.
LDRT has minimal side effects. Very few patients have experienced skin redness or irritation on areas of the body treated with LDRT.
There are low risks of secondary malignancy associated with LDRT that can be assessed based on factors like age, sex, and the part of the body being treated. The 2018 DEGRO guidelines recommend that LDRT be used primarily for patients older than 40 to minimize secondary malignancy risk.**
Between 50–65% of OA patients respond well to LDRT, and several clinical studies have been conducted on the impact of LDRT for relieving OA symptoms.*
Recent data shows that:
AHN experts are focused on enhancing and standardizing OA patient care through leading-edge radiation therapy techniques. To learn more about our Radiation Oncology Program or refer your patients to AHN for LDRT, call (412) DOCTORS.
*Source: The Use of Low-Dose Radiation Therapy in Osteoarthritis: A Review. Redjournal.org.
**Source: Updated strategies in the treatment of benign diseases—a patterns of care study of the german cooperative group on benign diseases. ScienceDirect.com.
***Source: The Use of Low-Dose Radiation Therapy in Osteoarthritis: A Review. ScienceDirect.com.
****Source: Low-dose radiation therapy for hand osteoarthritis: shaking hands again? NIH.gov
*****Source: Effects of low dose rate radiotherapy on pain relief, performance score, and quality of life in patients with knee osteoarthritis; a double-blind sham-controlled randomized clinical trial.NIH.gov